Tubeless hypotónic duodenography.
D000284:Administration, Oral; D001555:Benzene Derivatives / Q000009:adverse effects; D001561:Benzilates / Q000009:adverse effects; D003514:Cyclohexylamines / Q000009:adverse effects; D004378:Duodenal Diseases / Q000000981:diagnostic imaging*; D004379:Duodenal Neoplasms / Q000000981:diagnostic imaging*; D005069:Evaluation Studies as Topic; D005769:Gastrointestinal Motility / Q000187:drug effects*; D007038:Hypotonic Solutions; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008787:Metoclopramide / Q000009:adverse effects; D010880:Piperidines / Q000009:adverse effects; D011413:Propantheline / Q000009:adverse effects; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects; D011859:Radiography
D001555:Benzene Derivatives; D001561:Benzilates; D003514:Cyclohexylamines; D007038:Hypotonic Solutions; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; D011413:Propantheline; D008787:Metoclopramide